About Philip Kantoff
Form D filings for Convergent Therapeutics from 2023 to 2024 list Philip Kantoff as CEO and director.
Philip Kantoff first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Philip Kantoff in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Philip Kantoff works with at each company, as listed on that company's latest Form D.
Convergent Therapeutics, Inc. · Form D, Aug 13, 2024
ES
Eric Sullivan
Executive officer
JS
Jake Simson
Director
Tal Zaks
Director
JT
Jim Trenkle
Director
AB
Alexander Brown
Executive officer
NB
Neil Bander
Executive officer and director